within Pharmacolibrary.Drugs.ATC.H;

model H02AB09_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 13.7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.0257,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Hydrocortisone is a glucocorticoid hormone used as an anti-inflammatory and immunosuppressant agent. It is a synthetic form of cortisol and is widely used in the treatment of adrenal insufficiency (such as Addison's disease), severe allergies, asthma, and rheumatoid arthritis. Hydrocortisone is approved and commonly used in clinical practice both as oral and intravenous formulations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adults after a single intravenous bolus dose.</p><h4>References</h4><ol><li><p>Czock, D, et al., &amp; Häussler, U (2005). Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. <i>Clinical pharmacokinetics</i> 44(1) 61–98. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544010-00003&quot;>10.2165/00003088-200544010-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15634032/&quot;>https://pubmed.ncbi.nlm.nih.gov/15634032</a></p></li><li><p>Vincze, I, et al., &amp; Kopitkó, C (2022). Assessment of Antibiotic Pharmacokinetics, Molecular Biomarkers and Clinical Status in Critically Ill Adults Diagnosed with Community-Acquired Pneumonia and Receiving Intravenous Piperacillin/Tazobactam and Hydrocortisone over the First Five Days of Intensive Care: An Observational Study (STROBE Compliant). <i>Journal of clinical medicine</i> 11(14) –. DOI:<a href=&quot;https://doi.org/10.3390/jcm11144140&quot;>10.3390/jcm11144140</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35887904/&quot;>https://pubmed.ncbi.nlm.nih.gov/35887904</a></p></li><li><p>Labib, A (2019). Sepsis Care Pathway 2019. <i>Qatar medical journal</i> 2019(2) 4–None. DOI:<a href=&quot;https://doi.org/10.5339/qmj.2019.qccc.4&quot;>10.5339/qmj.2019.qccc.4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31763206/&quot;>https://pubmed.ncbi.nlm.nih.gov/31763206</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end H02AB09_1;
